InvestSMART

Integrated Research Limited (ASX:IRI)

ALERT: Price-sensitive ASX Announcement for IRI
Current share price for IRI : $0.270 -0.02 (-6.90%)+
Release
24 Nov 2025 9:20AM
Price at Release
$0.290
Full Release
download
Summary
The CEO's presentation at the 2025 Annual General Meeting of Integrated Research Limited highlighted the company's strategic shift towards product-led growth, emphasizing significant investment in new product development to create sustainable revenue streams. The company is focusing on expanding its client base and increasing subscription revenue, with the introduction of new products like Prognosis Elevate and the AI-powered Iris. The presentation also detailed a robust capital allocation framework aimed at supporting innovation, maintaining operational flexibility, and ensuring shareholder returns. While the company anticipates short-term profit reduction due to these investments, it remains confident in its long-term growth potential, backed by a strong balance sheet and a diverse client base.
Key Points
  • Focus on product-led growth for sustainable revenue.
  • Significant investment in new product development.
  • Introduction of Prognosis Elevate and AI-powered Iris.
  • Robust capital allocation for innovation and flexibility.
  • Anticipated short-term profit reduction due to investments.
  • Confidence in long-term growth backed by a strong balance sheet.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.